Bajaj Healthcare informs about appointment of additional director

05 Jan 2026 Evaluate

Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (‘Listing Regulations’) Bajaj Healthcare has informed that the Board of Directors of the Company, based on the recommendation of Nomination & Remuneration Committee, through a resolution passed by circulation on January 05, 2026, has considered and approved the appointment of Purnima Dhanraj Amin (DIN: 11461111) as an Additional Director (Non-Executive Independent Director Category) of the Company for a first term of five consecutive years, with effect from January 05, 2026 to January 04, 2031 subject to the approval of the Shareholders of the Company. Mrs. Purnima Dhanraj Amin has confirmed that she meets the criteria of ‘Independence’ under Section 149 of the Companies Act, 2013, and Regulation 16 of Listing Regulations. Further, she has also confirmed that she has not been debarred from holding the office of Director by virtue of any order passed by the Securities and Exchange Board of India or any other such authority in accordance with BSE Circular No. LIST/COMP/14/2018-19 and NSE Circular No. NSE/CML/2018/24 dated 20th June 2018. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 are given in Annexure A.

The above information is a part of company’s filings submitted to BSE.

Bajaj Healthcare Share Price

410.20 5.80 (1.43%)
07-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.50
Dr. Reddys Lab 1242.60
Cipla 1467.30
Zydus Lifesciences 927.20
Lupin 2213.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×